(Z/E)-4-(4-(4-[(2-oxoindolin-3-ylidene)methyl]phenyl)-1H-1,2,3-triazol-1-yl)benzonitrile

ID: ALA4872013

PubChem CID: 164624739

Max Phase: Preclinical

Molecular Formula: C24H15N5O

Molecular Weight: 389.42

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(-n2cc(-c3ccc(C=C4C(=O)Nc5ccccc54)cc3)nn2)cc1

Standard InChI:  InChI=1S/C24H15N5O/c25-14-17-7-11-19(12-8-17)29-15-23(27-28-29)18-9-5-16(6-10-18)13-21-20-3-1-2-4-22(20)26-24(21)30/h1-13,15H,(H,26,30)

Standard InChI Key:  ARVBBXCWMZRVJY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    0.8527   -2.0788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8515   -2.9062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5662   -3.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5644   -1.6662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2797   -2.0752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2845   -2.9062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0763   -3.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5609   -2.4832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0685   -1.8140    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3358   -3.9413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1437   -4.1082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3858   -2.4784    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3984   -4.8935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2054   -5.0606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7547   -4.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4914   -3.6577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6850   -3.4945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5641   -4.6078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9051   -5.3589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7249   -5.2668    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8906   -4.4587    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1732   -4.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6390   -4.1188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3100   -4.6006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0605   -4.2603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1414   -3.4384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4654   -2.9581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7177   -3.3010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8899   -3.0962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6406   -2.7542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  7 10  2  3
 10 11  1  0
  8 12  2  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 18  2  0
 15 18  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 21 23  1  0
 29 30  3  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872013

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKN-45 (2102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.42Molecular Weight (Monoisotopic): 389.1277AlogP: 4.30#Rotatable Bonds: 3
Polar Surface Area: 83.60Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.31CX Basic pKa: CX LogP: 4.86CX LogD: 4.86
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.53Np Likeness Score: -1.44

References

1. Wang DP, Liu KL, Li XY, Lu GQ, Xue WH, Qian XH, Mohamed O K, Meng FH..  (2021)  Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold.,  211  [PMID:33340911] [10.1016/j.ejmech.2020.113083]

Source